AQR Arbitrage’s Japer Therapeutics Warrants JSPRW Stock Holding History

AQR Arbitrage’s Portfolio JSPRW Stock Details JSPRW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-187,500	Closed	-$218K	–	1184
2021 Q2	$218K	Hold	187,500	–	–	0.01%	753
2021 Q1	$154K	Hold	187,500	–	–	0.01%	798
2020 Q4	$272K	Hold	187,500	–	–	0.01%	859
2020 Q3	$233K	Hold	187,500	–	–	0.01%	490
2020 Q2	$188K	Hold	187,500	–	–	0.01%	455
2020 Q1	$122K	Buy	+187,500	New	+$147K	﹤0.01%	508

Other funds holding JSPRW

OCAM

Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return

HCM

Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return

TCM

Tenor Capital Management New York $6.49B AUM 3.01% 1-Year Est. Return

SCM

Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

Zazove Associates Incline Village, Nevada $1.22B AUM 1.91% 1-Year Est. Return

Maven Securities St Helier, Jersey $5.2B AUM 44.01% 1-Year Est. Return

RCM

Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return

Bulldog Investors Saddle Brook, New Jersey $445M AUM 2.55% 1-Year Est. Return

Walleye Trading New York $60B AUM 42.19% 1-Year Est. Return

AQR Arbitrage's JSPRW Position: Q3 2021 in Review

AQR Arbitrage sold out of Japer Therapeutics Warrants (JSPRW) in Q3 2021, closing a stake of 187,500 shares — an estimated $218K sold.

AQR Arbitrage first reported a position in JSPRW in Q1 2020 and held it in 6 quarters. The position peaked at $272K in Q4 2020. 16 funds tracked by Wall St. Rank hold JSPRW as of Q3 2021.

AQR Arbitrage reported no remaining Japer Therapeutics Warrants position as of Q3 2021 after selling out during the quarter.
AQR Arbitrage sold 187,500 Japer Therapeutics Warrants shares in Q3 2021, an estimated $218K.
AQR Arbitrage first reported a position in Japer Therapeutics Warrants in Q1 2020 and held it in 6 quarters.
AQR Arbitrage's Japer Therapeutics Warrants position peaked at $272K in Q4 2020.
16 funds tracked by Wall St. Rank held Japer Therapeutics Warrants as of Q3 2021.

Based on AQR Arbitrage's 13F filing for Q3 2021, filed 15 Nov 2021.